| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1073: Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodies |
|
Medicine details |
|
| Medicine name | marstacimab (Hympavzi®) |
| Formulation | solution for infusion |
| Reference number | 4883 |
| Indication | Treatment of severe haemophilia A or severe haemophilia B in people 12 years and over |
| Company | Pfizer Ltd |
| BNF chapter | Nutrition & blood |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 12/12/2024 |
| NICE guidance | |